Utilizing melt crystallization fundamentals in the development of a new tabletting technology

Abstract

Increasing production effeciency and lowering costs are some of the many advantages melt crystallization technology offers over the conventional methodology of tabletting. A normal tablet consists of a pure shell or a coat and a separate core constituting the pharmaceutical active ingredient. Great emphasis is put on the purity of the shell since its purpose is to solely protect and deliver the active ingredient to its target. Melt crystallization is a purification (separation) process. It is discussed here for its ability to produce coated tablets, by separating the “coating” material from the “to be coated” material coming from one molten mixture. Molten drops of lutrol-ibuprofen mixture are produced using the drop forming technique. The subsequent analysis involves proving and quantifying the phase separation (coat purity). The mechanism of a crystallizing drop is shown as direct evidence of the ongoing process. Moreover, solidified tablet batches are analyzed for the purity of their coating by measuring the ibuprofen concentration. This optimization process is carried out through multiple stages of development and condition enhancements in order to produce the most pure tablet coating. As a result, a trial showing an almost purely coated tablet is presented here.

Keywords

phase separation / melt crystallization / tablets / process optimization

References

[1] Lieberman H, Lachman L, Schwartz J. Pharmaceutical Dosage Forms: Tablets Volume 1. New York: Marcel Dekker, 1989

[2] Kim K J. Impurity distributions in crystalline solid layer in melt crystallization. Dissertation for the Doctoral Degree. Aachen: Martin Luther University Halle-Wittenberg, 2001, 1–2

[3] Ulrich J, Glade H. Melt Crystallization-Fundamentals, Equipment and Applications. Aachen: Shaker Verlag, 2003, 41

[4] Abouzeid A, Petersen S, Ulrich J. Optimized coating through phase separation in tablets by melt crystallization. Chemical Engineering & Technology, 2014, 37(8): 1369–1375

[5] Rowe R, Sheskey P, Quinn M. Handbook of Pharmaceutical Excipients. London: Pharmaceutical Press and American Pharmacists Association, 2009, 383, 506–507

[6] Gershanov V, Garmashov S. Non-stationary nonlinear effects at mass transfer in small volumes of solution in melt enclosed in anisotropic crystal. Journal of Crystal Growth, 2009, 311(9): 2722–2730

Acknowledgments

The results are an outcome of the VIP project “In situ Beschichtung” supported by the Federal Ministry of Education and Research of the German Federal Republic. Further researchers in the project are A. Hartwig and K. Wendt.

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg